Skip to main content
Caplight Logo









Cytotrait

Cytotrait

Private
ManchesterHealthcare & Life Scienceshttps://www.cytotrait.com/

Last Round

Seed

Mar 9, 2026

Total Funding Raised

$5.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cytotrait is a biotechnology company that develops organelle-targeted gene editing technology to engineer novel traits in food and agricultural crops.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

circulating tumor cellsCTCliquid biopsymicrofluidicsprecision oncologycell isolationcancer diagnosticsmolecular profilingbiotech equipmentnon-invasive diagnosticslab-on-a-chipcancer research tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytotrait Comparables

Compare Cytotrait with similar companies based on industry and business-model similarity.

Cytotrait comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vortex Biosciences
86%
SmartCatch
81%
Cell Microsystems
81%

Cytotrait Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 9, 2026
GrantSep 1, 2025

Cytotrait Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 9, 2026

    $4M round led by Northern Gritstone.

  • Sep 1, 2025

    $670K grant received from Advanced Research and Invention Agency.

Cytotrait Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cytotrait Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytotrait's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester
Employee Range5
Year Founded2026
Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?